Aptorum Group Announces Shareholder Approval of Proposed Merger with DiamiR Biosciences
Aptorum Group Limited (NASDAQ: APM) announced that its shareholders approved an all-stock merger with DiamiR Biosciences, a company specializing in innovative blood-based diagnostic tests for brain health. DiamiR's shareholders also approved the transaction, which will make DiamiR a wholly owned subsidiary of Aptorum. The merger aims to combine the…